430 related articles for article (PubMed ID: 33673861)
1.
Ledoult E; Morelle M; Soussan M; Mékinian A; Béhal H; Sobanski V; Hachulla E; Huglo D; Le Gouellec N; Remy-Jardin M; Baillet C; Launay D
Arthritis Res Ther; 2021 Mar; 23(1):76. PubMed ID: 33673861
[TBL] [Abstract][Full Text] [Related]
2. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
Peelen DM; Zwezerijnen BGJC; Nossent EJ; Meijboom LJ; Hoekstra OS; Van der Laken CJ; Voskuyl AE
Rheumatology (Oxford); 2020 Jun; 59(6):1407-1415. PubMed ID: 31642912
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.
Nobashi T; Kubo T; Nakamoto Y; Handa T; Koyasu S; Ishimori T; Mishima M; Togashi K
J Nucl Med; 2016 Dec; 57(12):1899-1904. PubMed ID: 27339874
[TBL] [Abstract][Full Text] [Related]
4. PET/CT and inflammatory mediators in systemic sclerosis-associated interstitial lung disease.
Bastos AL; Ferreira GA; Mamede M; Mancuzo EV; Teixeira MM; Santos FPST; Ferreira CS; Correa RA
J Bras Pneumol; 2022; 48(4):e20210329. PubMed ID: 35674522
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of
Akaike K; Saruwatari K; Oda S; Shiraishi S; Takahashi H; Hamada S; Iyama S; Horio Y; Tomita Y; Saeki S; Okamoto S; Ichiyasu H; Fujii K; Sakagami T
Int J Clin Oncol; 2020 Apr; 25(4):681-690. PubMed ID: 31781994
[TBL] [Abstract][Full Text] [Related]
6. Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors.
Forestier A; Le Gouellec N; Béhal H; Kramer G; Perez T; Sobanski V; Dubois SM; Lambert M; Hatron PY; Hachulla E; Duhamel A; Matran R; Launay D; Rémy-Jardin M
Semin Arthritis Rheum; 2020 Dec; 50(6):1406-1413. PubMed ID: 32245698
[TBL] [Abstract][Full Text] [Related]
7. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
9. Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
Fraz MSA; Moe N; Revheim ME; Stavrinou ML; Durheim MT; Nordøy I; Macpherson ME; Aukrust P; Jørgensen SF; Aaløkken TM; Fevang B
Front Immunol; 2020; 11():617985. PubMed ID: 33584710
[TBL] [Abstract][Full Text] [Related]
10. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
11. (18)FDG uptake associated with CT density on PET/CT in lungs with and without chronic interstitial lung diseases.
Inoue K; Okada K; Taki Y; Goto R; Kinomura S; Fukuda H
Ann Nucl Med; 2009 May; 23(3):277-81. PubMed ID: 19319629
[TBL] [Abstract][Full Text] [Related]
12. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
Yamakawa H; Takemura T; Iwasawa T; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Iso S; Okudela K; Kuwano K; Ogura T
BMC Pulm Med; 2018 Jan; 18(1):25. PubMed ID: 29382307
[TBL] [Abstract][Full Text] [Related]
13. Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting.
Jordon LH; Ganeshan B; Nadeem I; Hoy L; Mahdi N; Porter JC; Groves A; Win T
BMJ Open; 2024 May; 14(5):e081103. PubMed ID: 38816048
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of
Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
[No Abstract] [Full Text] [Related]
15. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
[TBL] [Abstract][Full Text] [Related]
16. Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function.
van den Hombergh WMT; Simons SO; Teesselink E; Knaapen-Hans HKA; van den Hoogen FHJ; Fransen J; Vonk MC
Clin Rheumatol; 2018 Oct; 37(10):2715-2722. PubMed ID: 29987427
[TBL] [Abstract][Full Text] [Related]
17. Association of Computed Tomography Densitometry with Disease Severity, Functional Decline, and Survival in Systemic Sclerosis-associated Interstitial Lung Disease.
Saldana DC; Hague CJ; Murphy D; Coxson HO; Tschirren J; Peterson S; Sieren JP; Kirby M; Ryerson CJ
Ann Am Thorac Soc; 2020 Jul; 17(7):813-820. PubMed ID: 32191491
[No Abstract] [Full Text] [Related]
18. Advanced and traditional chest MRI sequence for the clinical assessment of systemic sclerosis related interstitial lung disease, compared to CT: disease extent analysis and correlations with pulmonary function tests.
Landini N; Orlandi M; Calistri L; Nardi C; Ciet P; Bellando-Randone S; Guiducci S; Benkert T; Panebianco V; Morana G; Matucci-Cerinic M; Colagrande S
Eur J Radiol; 2024 Jan; 170():111239. PubMed ID: 38056347
[TBL] [Abstract][Full Text] [Related]
19. Deep-inspiration breath-hold 18F-FDG-PET/CT is useful for assessment of connective tissue disease associated interstitial pneumonia.
Uehara T; Takeno M; Hama M; Yoshimi R; Suda A; Ihata A; Ueda A; Tateishi U; Ishigatsubo Y
Mod Rheumatol; 2016; 26(1):121-7. PubMed ID: 25995034
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease.
Jang HJ; Woo A; Kim SY; Yong SH; Park Y; Chung K; Lee SH; Leem AY; Lee SH; Kim EY; Jung JY; Kang YA; Kim YS; Park MS
Ann Med; 2023 Dec; 55(1):663-671. PubMed ID: 37074318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]